Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Use of Disease-Modifying Therapies in Pediatric MS.
AMP-Activated Protein Kinase Suppresses Autoimmune Central Nervous System Disease by Regulating M1-Type Macrophage-Th17 Axis.
Selective hair cell ablation and noise exposure lead to different patterns of changes in the cochlea and the cochlear nucleus.
CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?
Is disability measured by FIM a predictor for successful self-intermittent catheterization in neurological patients?
Unilateral olfactory sensitivity in multiple sclerosis.
Antioxidant Protection of NADPH-Depleted Oligodendrocyte Precursor Cells Is Dependent on Supply of Reduced Glutathione.
Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.
Leukodystrophies.
Clinical Features and Visual Outcomes of Optic Neuritis in Chinese Children.
Restriction spectrum imaging reveals decreased neurite density in patients with temporal lobe epilepsy.
Low T3 syndrome in neuromyelitis optica spectrum disorder: Associations with disease activity and disability.
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis.
Effects of Inflammasome Activation on Secretion of Inflammatory Cytokines and Vascular Endothelial Growth Factor by Retinal Pigment Epithelial Cells.
Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.
[The value of brain magnetic resonance imaging in the early diagnosis of neuropsychiatric systemic lupus erythematosus].
Autoimmune Myopathies: Where Do We Stand?
Ocular syphilis in patients with Human Immunodeficiency Virus infection.
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes.
The restoration of conduction by central remyelination.
The 'best' basic science paper on multiple sclerosis in 2012.
SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
First use of alemtuzumab in balo concentric sclerosis: a case report.

Pages